Mariani Javier, Garau María Laura, Roitman Adriel Jonas, Vukotich Claudia, Perelis Leonardo, Ferrero Fernando, Domínguez Adriana Gladys, Campos Cecilia, Serrano Cecilia, Villa Monte Gabriel González
Coronary Unit Coordinator, Hospital de Alta Complejidad en Red "El Cruce", Buenos Aires, Argentina.
Comité Central de Ética en Investigación, Ministerio de Salud del Gobierno de la Ciudad de Buenos Aires, Ciudad Autónoma de Buenos Aires, Argentina.
J Empir Res Hum Res Ethics. 2023 Feb-Apr;18(1-2):69-77. doi: 10.1177/15562646221134620. Epub 2022 Oct 25.
It has been reported that significant variability in the ethics review process affects multisite studies. We analyzed 1,305 applications for multicenter studies (409 unique protocols), from 1 January 2020 to 20 September 2021. We examined the variability in the times to approval and the first observation and the variation in the level of risk assigned. The median [IQR] variabilities were 42.19 [15.23-82.36] days and 8.00 [3.12-16.68] days, for the times to approval and to the first observation, respectively. There was disagreement in the level of risk assigned by the Research Ethics Committee (REC) in 24.0% of cases. Independent predictors of variability included the number of REC members. In our study, we found substantial variability in the ethics review process among health research protocols. Also, we describe methods to readily measure the delays and the variations in the ethics review process.
据报道,伦理审查过程中的显著差异会影响多中心研究。我们分析了2020年1月1日至2021年9月20日期间1305份多中心研究申请(409个独特方案)。我们研究了批准时间和首次观察时间的差异以及所分配风险水平的差异。批准时间和首次观察时间的中位数[四分位间距]差异分别为42.19[15.23 - 82.36]天和8.00[3.12 - 16.68]天。研究伦理委员会(REC)在24.0%的案例中对所分配的风险水平存在分歧。差异的独立预测因素包括REC成员数量。在我们的研究中,我们发现健康研究方案的伦理审查过程存在很大差异。此外,我们描述了便于衡量伦理审查过程中的延迟和差异的方法。